Download PDF
Thromb Haemost 1991; 65(02): 139-143
DOI: 10.1055/s-0038-1647472
Original Article
Schattauer GmbH Stuttgart

Factors Affecting the lnteraction of Tissue Factor/Factor Vll with Factor X in a Heterogeneous Tubular Reactor

Cynthia H Gemmell
The Department of Medicine, Mount Sinai Medical Center, New York, NY USA
,
Vincet T Turitto
The Department of Medicine, Mount Sinai Medical Center, New York, NY USA
,
Yale Nemerson
The Department of Medicine, Mount Sinai Medical Center, New York, NY USA
› Author Affiliations
Further Information

Publication History

Received: 02 May 1990

Accepted after revision 04 September 1990

Publication Date:
02 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints

Summary

A novel reactor recently described for studying phospholipiddependent blood coagulation reactions under flow conditions similar to those occurring in the vasculature has been further charactenzed. The reactor is a capitlary whose inner wall is coated with a stable phospholipid bilayer (or two bilayers) containing tissue factor, a transmembrane protein that is required for the enzymatic activation of factor X by factor VIIa. Perfusion of the capillary at wall shear rates ranging from 25 s−1 to 1,200 s−1 with purified bovine factors X and VIIa led to steady state factor Xa levels at the outlet. Assay were performed using a chromogenic substrate, SpectrozymeTMFXa, or by using a radiometric technique. In the absence of Ca2+ or factor VIIa there was no product formation. No difference was noted in the levels of factor Xa achieved when non-activated factor VII was perfused. Once steady state was achieved further factor Xa production continued in the absence of factor VIIa implying a very strong association of factor VIIa with the tissue factor in the phospholipid membrane. In agreement with static vesicle-type studies the reactor was sensitive to wall tissue factor concentration, temperature and the presence of phosphatidylserine in the bilayer.

 

  • References

  • 1 Nemerson Y. Characteristics and lipid requirements of coagulation proteins extracted from brhin and lungr tt " specificity of the protein component of tissue factor. J Clin Invest 1961; 48: 322-331
    PubMedGoogle Scholar
  • 2 Carson SD, Konigsberg WH. Cadmium increases tissue factor (and coagulation factor III) activity by facilitating its reassociation with lipids. Science 1980; 208: 307-309
    CrossrefPubMedGoogle Scholar
  • 3 Bach R, Nemerson Y, Konigsberg W. Purification and characteization of bovine tissue factor. J Biol Chem 1981; 256: 8324-8331
    PubMedGoogle Scholar
  • 4 Bach R, Gentry R, Nemerson Y. Factor VII binding to tissue factor in reconstituted phospholipid vesicles: Induction of cooperativity by phosphatidylserine. Biochemistry 1986; 25: 4007-4020
    CrossrefPubMedGoogle Scholar
  • 5 Brian AA, McConnell HM. Allogeneic stimulation of cytotoxic t cells by supported planar membranes. Proc Natl Acad Sci 1984; 81: 6159-6163
    CrossrefPubMedGoogle Scholar
  • 6 Watts TH, Brian AA, Kappler JW, Marrack R, McConnell HM. Antigen presentation by supported planar membranes containing affinity-purified I-Ad. Proc Natl Acad Sci 1984; 81: 7564-7568
    CrossrefPubMedGoogle Scholar
  • 7 Subramanian S, Seul M, McConnell HM. Lateral diffusion of specific antibodies bound to lipid monolayers on alkylated substrates. Proc Natl Acad Sci 1986; 83: 1169-1173
    CrossrefPubMedGoogle Scholar
  • 8 Thamm LK, McConnell HM. Supported phospholipid bilayers. Biophys J 1985; 47: 105-113
    CrossrefPubMedGoogle Scholar
  • 9 Gemmell CH, Turitto VT, Nemerson Y. Flow as a regulator of the activation of factor X by tissue factor. Blood 1988; 72: 1404-1406
    PubMedGoogle Scholar
  • 10 Gemmell CH, Turitto VT, Nemerson Y. The effect of shear rate on the enzymatic activity of the tissue factor-factor VIIa complex. (in press)
    Google Scholar
  • 11 Papahadjopoulos D, Poste G, Schaeffer BE, Vail WJ. Membrane fusion and molecular segregation in phospholipid vesicles. Biochim Biophys Acta 1974; 352: 10-28
    CrossrefPubMedGoogle Scholar
  • 12 Bird RB, Stewart WE, Lightfoot EN. Tiansport Phenomena. John Wiley & Sons, Inc; New York: 1960: 46
    Google Scholar
  • 13 Kiesel W, Fujikawa K, Davie EW. Activation of bovine factor VII (proconvertin) by factor XIIa (activated Hageman factor). Biochemistry 1977; 16: 4189-4194
    CrossrefPubMedGoogle Scholar
  • 14 Jesty J, Nemerson Y. The activation of bovine coagulation factor X. Methods Enzymol 1976; 45: 95-107
    PubMedGoogle Scholar
  • 15 Zur M, Nemerson Y. Radiometric assays for blood coagulation factors. Methods Enzymol 1981; 80: 237-249
    PubMedGoogle Scholar
  • 16 Bach R, Oberdick J, Nemerson Y. Immunoaffinity Purification of Bovine factor VII. Blood 1984; 63: 393-398
    PubMedGoogle Scholar
  • 17 Forman SD, Nemerson Y. Membrane-dependent coagulation reaction is independent of the concentration of phospholipid-bound substrate; fluid phase factor X regulates the extrinsic system. Proc Natl Acad Sci 1986; 83: 4675-4679
    CrossrefPubMedGoogle Scholar
  • 18 Nemerson Y, Gentry R. An ordered addition, essential activation model of the tissue factor pathway of coagulation: Evidence for a conformational cage. Biochemistry 1986; 25: 4020-4033
    CrossrefPubMedGoogle Scholar
  • 19 Nemerson X, Repke D. Tissue factor accelerates the activation of coagulation factor VII. The role of a bifunctional coagulation cofactor. Thromb Res 1985; 40: 351-358
    PubMedGoogle Scholar
  • 20 Rao LVM, Rappaport SI. Activation of factor VII bound to tissue factor: A key early step in the tissue factor pathway of blood coagulation. Proc Natl Acad Sci USA 1988; 85: 6687-6691
    CrossrefPubMedGoogle Scholar
  • 21 Broze Jr GJ. Binding of human factor VII and VIIa to monocytes. J Clin Invest 1982; 70: 526-535
    CrossrefPubMedGoogle Scholar